Acinetobacter Baumannii Cell Envelope ✉ Edward Geisinger 1,2 , Nadav J

Acinetobacter Baumannii Cell Envelope ✉ Edward Geisinger 1,2 , Nadav J

ARTICLE https://doi.org/10.1038/s41467-020-18301-2 OPEN Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope ✉ Edward Geisinger 1,2 , Nadav J. Mortman2, Yunfei Dai1, Murat Cokol 2,3, Sapna Syal2, Andrew Farinha1, Delaney G. Fisher 2, Amy Y. Tang1, David W. Lazinski2, Stephen Wood4, Jon Anthony4, Tim van Opijnen 4 & ✉ Ralph R. Isberg 2 1234567890():,; A unique, protective cell envelope contributes to the broad drug resistance of the nosocomial pathogen Acinetobacter baumannii. Here we use transposon insertion sequencing to identify A. baumannii mutants displaying altered susceptibility to a panel of diverse antibiotics. By examining mutants with antibiotic susceptibility profiles that parallel mutations in char- acterized genes, we infer the function of multiple uncharacterized envelope proteins, some of which have roles in cell division or cell elongation. Remarkably, mutations affecting a pre- dicted cell wall hydrolase lead to alterations in lipooligosaccharide synthesis. In addition, the analysis of altered susceptibility signatures and antibiotic-induced morphology patterns allows us to predict drug synergies; for example, certain beta-lactams appear to work cooperatively due to their preferential targeting of specific cell wall assembly machineries. Our results indicate that the pathogen may be effectively inhibited by the combined targeting of multiple pathways critical for envelope growth. 1 Department of Biology, Northeastern University, Boston, MA 02115, USA. 2 Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, MA 02111, USA. 3 Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA. 4 Biology Department, Boston ✉ College, Chestnut Hill, MA 02467, USA. email: [email protected]; [email protected] NATURE COMMUNICATIONS | (2020)11:4522 | https://doi.org/10.1038/s41467-020-18301-2 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18301-2 he World Health Organization, Food and Drug Adminis- Results Ttration, and Centers for Disease Control each rank Defining drug susceptibility determinants in A. baumannii.To restriction of Acinetobacter baumannii as among the most examine the genome-wide molecular mechanisms that mod- critical targets for developing new antimicrobials1–3. This Gram- ulate antibiotic action in A. baumannii, we measured the effects negative rod causes drug-resistant nosocomial diseases in the of transposon insertion mutations on bacterial growth during critically ill, commonly manifesting as bloodstream infections and challenge with a broad set of antimicrobial compounds by Tn- ventillator-associated pneumonia4. Resistance to an extensive seq12. Antibiotics were selected that target a variety of essential range of antibiotics, including formerly last-resort agents such as cellular processes, with about half of the treatments targeting carbapenems, is now widespread among A. baumannii isolates, the cell envelope (Fig. 1). This subset includes antibiotics that with the emergence of strains resistant to all available antibiotics target distinct aspects of cell wall biogenesis governing elon- now documented5,6. Few therapeutic options remain to control gation or division. In addition to defining elements of intrinsic this threat. drug susceptibility, the use of multiple distinct stress conditions A better understanding of what makes A. baumannii so diffi- facilitates the determination of specific fitnessphenotypesfora cult to treat is critical for improved strategies that attack the large swath of genes in A. baumannii. The relatedness of these pathogen. The evolution of drug resistance in A. baumannii in fitness profiles is predicted to provide leads regarding the large part is due to acquisition of inactivating enzymes or drug function of uncharacterized proteins that contribute to drug target mutations blocking antibiotic lethal action7,8. These resistance. acquired alterations, which vary across isolates, act in concert To measure the effect of each antibiotic on relative fitness of with conserved mechanisms tightly linked to reduced drug transposon mutants, we used previously constructed random penetration, including a low-permeability cell envelope and banks of A. baumannii ATCC 17978 Tn10 insertion mutants20 as upregulation of efflux pumps9,10. Insight into the intrinsic well as random banks of Himar1 mariner mutants constructed for envelope-level defenses has the potential to inform ways to these purposes (Methods). For each transposon, 10 independent enhance antibiotic killing across diverse isolates. insertion pools, each consisting of 5000–20,000 unique mutants A powerful approach to revealing the genetic contributions to (>60,000 mutants in total with Tn10, >85,000 mutants with intrinsic mechanisms of drug defense is via high-density knockout mariner), were seeded in rich broth at A600 0.003 (approximately, mutant libraries, which allow measurement of genotype–phenotype 2.5 × 106 CFU/ml) in the presence or absence of antibiotic. relationships on a genome-wide scale11,12. This approach has been Antibiotics were used below the minimal inhibitory concentra- used to identify genes modulating susceptibility to a variety of tions (MIC) such that growth rate was lowered by 20–30% antibiotic stresses13–18, and has been used to identify intrinsic compared to growth without antibiotics (Supplementary Table 1), defenses against a selection of antimicrobial treatments in A. a degree of selective pressure enabling detection of mutants with baumannii9,19,20. Despite the utility of these approaches in mea- altered susceptibilities20. In the case of sulbactam (SLB; all suring gene–antibiotic interactions, understanding the mechanisms abbreviations listed in Fig. 1 and Supplementary Table 1), an behind the uncovered resistance determinants is limited by diffi- important component of empiric antibiotic therapy for A. culties associated with providing accurate gene annotations. A large baumannii infections, we tested an additional, lower concentra- fraction of genes in any organism lack characterization and have no tion resulting in 10–15% growth inhibition that should detect known or predicted function (referred to as “orphan” or “hypo- only the strongest elements of intrinsic resistance to the drug. ” 13,21,22 thetical genes) . Lack of functional information complicates Both treated and untreated cultures were allowed to grow to A600 downstream analyses, and single gene–antibiotic phenotypes can 0.5–1 (8 doublings). DNA was isolated from samples taken at the be insufficient to generate hypotheses on function. Moreover, in start and end of this outgrowth, and transposon insertion sites species divergent from model organisms, functional annotations were polymerase chain reaction (PCR)-amplified and enumerated predicted by sequence homologies are often inaccurate, as the by massively parallel sequencing. Read counts mapping to the function of sequence orthologs may not be conserved22,23.Hypo- chromosome and plasmid pAB3 were used to calculate a thetical genes lacking annotation and genes with inaccurate anno- normalized value of the fitness of each individual transposon tation due to noncanonical functions are predicted to be particularly mutant relative to the entire pool using established methods20. problematic with Acinetobacter, which has diverged from other γ- Fitness data across all pools from all mutants mapping to the proteobacteria and lacks many canonical proteins that function in same gene were then aggregated to generate a gene-level fitness envelope biogenesis10,24. A notable area of divergence involves value (Supplementary Data 1), which was used to assess the processes related to cell division. Key proteins that coordinate cell contribution of each gene to antibiotic-specific growth. envelope ingrowth and septum formation with chromosome The population-wide Tn-seq fitness method incorporates informa- replication (such as ZapB and SlmA) and cell separation (FtsEX) tion from two points in growth, so the effects of chromosome have no orthologs in Acinetobacter24. position bias observed previously25 are largely negated. An exception In this paper, we comprehensively characterize mechanisms of was the aminoglycoside tobramycin (TOB), which caused chromo- intrinsic defense in A. baumannii against multiple antibiotics via some origin-proximal genes to show higher average fitness scores transposon sequencing (Tn-seq) and leverage the diversity of than those of terminus-proximal genes (Supplementary Fig. 1). To phenotypes generated to address the problem of uncharacterized eliminate position bias, fitness values from TOB treatment were gene function in this pathogen. By analyzing the patterns of normalized by fitting to a locally weighted scatterplot smoothing altered antibiotic susceptibility caused by gene-inactivating (LOWESS) curve. The other case of position bias was seen with the mutations across the genome, we uncover functional relation- fluoroquinolone levofloxacin (LEV), but fitness values were asso- ships of conserved hypothetical proteins with key cell biological ciated with the region of two prophages (Supplementary Fig. 1, red processes and expand the roles of annotated enzymes in envelope arrowheads). We demonstrated previously that these increases are synthesis. The identified determinants of susceptibility represent associated with a DNA gyrase block in a fluoroquinolone-sensitive novel targets for potentiating

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    16 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us